)
Puneet Wadhwa leads all stock & financial markets’ coverage at Business Standard. He has an experience of over two decades in managing India’s busiest print, digital and electronic newsrooms at the Outlook Group, NDTV and Hindustan Times.
Puneet Wadhwa leads all stock & financial markets’ coverage at Business Standard. He has an experience of over two decades in managing India’s busiest print, digital and electronic newsrooms at the Outlook Group, NDTV and Hindustan Times.
The crackdown could entail more transaction disclosure, raise tax on cash, restrict cash holdings
The outcome confirms that the Prime Minister should have a second term in government, Wood says
Since the beginning of CY17, the markets have gained nearly 12% in a liquidity driven rally.
In the last two months, Tata Power has witnessed biggest drop in the mutual fund holding
Mid-caps will also do well in the current situation where DII have seen big inflows, says Arora
N Chandrasekaran, Tata Son's next chairman, drew Rs 25.6 cr in FY16, including perks, variable pay
In a Q&A, head of research at Ashmore Investment Mgt says he's bullish about FII inflows to India
RBI keeps repo rate steady at 6.25%; reverse repo and bank rate stand at 5.75% and 6.75%
We are in a huge asset bubble worldwide, Faber believes
Besides Budget, markets will be driven by global events and the outcome of Assembly elections
Here is a quick compilation of top stock recommendations for calendar year 2017 from brokerages
Dennis says that he sees a modest pick-up in global growth
Interview with managing director and head, Global Emerging Markets, UBS Securities
Interview with Jyotivardhan Jaipuria, Managing Director of Veda Investment Managers
Demonetisation impact, earnings growth, central bank policies are key things that will get attention
Marksans Pharma, RCom, Just Dial, Jet Airways, Idea Cellular and Jubilant FoodWorks have lost 40% - 61%, data show
Interview with managing director and head of equities, India, Nomura
On the other hand, classical defensive plays like information technology and pharmaceuticals have recorded a negative return of 9% and 10% respectively
Interview with Jigar Shah
Interview with India Strategist at Japan-based Mizuho Bank